S
BSX icon

Sunpointe’s Boston Scientific BSX Stock Holding History

Sunpointe’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Buy
+9,612
New +$522K 0.12% 163

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sunpointe's BSX Position: Q2 2026 in Review

Sunpointe opened a new position in Boston Scientific (BSX) in Q2 2026: 9,612 shares worth $410K. The stake represents 0.12% of the portfolio and ranks #163 among its holdings.

1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sunpointe held 9,612 shares of Boston Scientific worth $410K as of Q2 2026.
  • Boston Scientific was a new Sunpointe position in Q2 2026.
  • Boston Scientific made up 0.12% of Sunpointe's portfolio in Q2 2026, its #163 holding.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.